# Leslie Wilberforce

> Leslie Oley Wilberforce is the CEO of Evidation, a San Mateo-based digital health company that has built a 5-million-person platform where individuals share permissioned health data to power real-world clinical research. A mechanical engineer by training (BS Penn State, MS Stanford), she joined Evidation in 2015 and spent a decade building the company's enterprise technology platform and landmark partnerships with Johnson & Johnson, Apple, the Michael J. Fox Foundation, and the American Heart Association before becoming Evidation's first non-founder CEO in March 2025.

- **Role:** CEO at Evidation
- **Organizations:** Evidation, Boston Scientific, ApniCure, Voyage Medical
- **Nationality:** American
- **Education:** BS, Mechanical Engineering, Pennsylvania State University, MS, Mechanical Engineering (NSF-funded biomechanics research), Stanford University
- **Known for:** First non-founder CEO of Evidation, appointed March 2025, Led creation of Evidation's enterprise product and technology platform, Forged landmark research partnerships with The Michael J. Fox Foundation, The American Heart Association, Johnson & Johnson, and Apple

## Career timeline

- **2005-2009** — R&D Engineer, Global Product Manager, Sr. Product Manager at Boston Scientific
- **2009-2012** — Product strategy and commercialization roles at Voyage Medical
- **2012-2015** — Sr. Director of Product Management & Growth Marketing at ApniCure; led strategy for consumer sleep apnea therapy that won IDEA and Wall Street Journal Technology Innovation Awards
- **2015** — Joined Evidation Health
- **2015-2024** — Rose from product and consumer roles to President & Chief Operating Officer at Evidation; spearheaded creation of enterprise product and technology platform
- **2020** — Played key role in the landmark Heartline Study with Johnson & Johnson and Apple - a 150,000-person virtual study on AFib detection using Apple Watch
- **2025-03** — Appointed CEO of Evidation, succeeding co-founder Christine Lemke - becoming the company's first non-founder leader

## Achievements

- First non-founder CEO of Evidation, appointed March 2025
- Led creation of Evidation's enterprise product and technology platform
- Forged landmark research partnerships with The Michael J. Fox Foundation, The American Heart Association, Johnson & Johnson, and Apple
- Key architect of the Heartline Study - the first virtual, site-less clinical trial using Apple Watch and iPhone
- Scaled Evidation to 5 million participants across 97% of US zip codes
- At ApniCure, led product that won both IDEA Award and Wall Street Journal Technology Innovation Award
- NSF-funded biomechanics research at Stanford University
- Enrolled 100,000 participants in a cardiometabolic study within two weeks

## Latest updates

- **2025-03** — Appointed CEO of Evidation, succeeding co-founder Christine Lemke
- **2025-03** — Announced partnership between Evidation and the American Heart Association's Research Goes Red program
- **2025-05** — Published perspective in STAT News on re-centering real-world data on the individual

## Links

- Website: https://evidation.com/about-us/leslie-oley-wilberforce
- LinkedIn: http://www.linkedin.com/in/leslie-oley

---

Profile page: https://yespress.io/leslie-wilberforce
Published by YesPress — https://yespress.io
Last updated: 2026-05-12